PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.28%
Revenue growth 1.25-1.5x 3391.T's 3.17%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
3.84%
Gross profit growth 1.25-1.5x 3391.T's 3.16%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
-5.56%
Negative EBIT growth while 3391.T is at 39.56%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
0.34%
Operating income growth under 50% of 3391.T's 25.99%. Michael Burry would be concerned about deeper cost or sales issues.
-15.18%
Negative net income growth while 3391.T stands at 47.48%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.18%
Negative EPS growth while 3391.T is at 47.42%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.18%
Negative diluted EPS growth while 3391.T is at 47.61%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 3391.T's 0.09%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
48.93%
10Y CAGR of 48.93% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
63.76%
5Y revenue/share CAGR at 50-75% of 3391.T's 102.04%. Martin Whitman would worry about a lagging mid-term growth trajectory.
39.15%
3Y revenue/share CAGR at 50-75% of 3391.T's 52.46%. Martin Whitman would question if the firm lags behind competitor innovations.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
80.40%
10Y net income/share CAGR of 80.40% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
56.52%
5Y net income/share CAGR at 50-75% of 3391.T's 76.76%. Martin Whitman might see a shortfall in operational efficiency or brand power.
44.96%
3Y net income/share CAGR above 1.5x 3391.T's 22.13%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
137.78%
5Y equity/share CAGR above 1.5x 3391.T's 81.41%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
66.52%
3Y equity/share CAGR above 1.5x 3391.T's 38.85%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Cut dividends over 10 years while 3391.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-98.55%
Firm’s AR is declining while 3391.T shows 3.15%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.93%
Inventory is declining while 3391.T stands at 5.76%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.74%
Asset growth well under 50% of 3391.T's 5.52%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.67%
BV/share growth above 1.5x 3391.T's 2.04%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-38.23%
We’re deleveraging while 3391.T stands at 82.92%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
102.83%
We expand SG&A while 3391.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.